Expert Opinion

Get A Second Opinion

The medical second opinion will be presented to you within 48 hours.

Preimplantation Genetic Diagnosis

Preimplantation Genetic Diagnosis 1

Preimplantation Genetic Diagnosis (PGD) is a technique used in assisted reproductive technology to screen embryos for genetic disorders before implantation. This procedure involves the removal of one or more cells from embryos created through in vitro fertilization (IVF) and analyzing these cells for specific genetic conditions. PGD allows for the selection of embryos that are free from certain genetic abnormalities, increasing the chances of a successful pregnancy and reducing the risk of passing on genetic disorders to offspring.

The process of PGD begins with the stimulation of the ovaries to produce multiple eggs, which are then fertilized with sperm in a laboratory setting to create embryos. After a few days of development, typically when the embryos reach the 6-8 cell stage, a small number of cells are removed from each embryo for genetic testing. The cells are then analyzed using techniques such as polymerase chain reaction (PCR), fluorescent in situ hybridization (FISH), or next-generation sequencing to identify genetic abnormalities.

PGD can be used to screen for a wide range of genetic conditions, including single gene disorders like cystic fibrosis and sickle cell anemia, chromosomal abnormalities such as Down syndrome, and genetic mutations associated with conditions like Huntington’s disease or BRCA gene mutations. By identifying embryos that are free from these genetic abnormalities, PGD can help couples make informed decisions about which embryos to implant during IVF, increasing the likelihood of a successful pregnancy and reducing the risk of passing on genetic disorders to future generations.

Who should have Preimplantation Genetic Diagnosis (PGD)?

Determining who should undergo Preimplantation Genetic Diagnosis (PGD) involves a consideration of various factors, including medical history, age, and genetic risk factors. Couples who may benefit from PGD include those with a known history of genetic disorders, chromosomal abnormalities, or recurrent pregnancy loss. Individuals with a family history of inherited conditions or those who are carriers of genetic mutations may also be candidates for PGD.

PGD is commonly recommended for couples who are carriers of genetic conditions that have a high risk of being passed on to their offspring. This includes individuals with autosomal dominant or recessive disorders, X-linked conditions, or chromosomal abnormalities that could result in severe health issues or developmental disabilities in the child. By screening embryos for these genetic abnormalities, PGD can help reduce the likelihood of passing on these conditions to future generations.

Advanced maternal age is another factor that may warrant the use of PGD. Women over the age of 35 have an increased risk of chromosomal abnormalities in their eggs, which can lead to conditions like Down syndrome in offspring. By undergoing PGD, older women can screen embryos for chromosomal abnormalities and select those with a higher likelihood of successful implantation and healthy development.

Additionally, couples who have experienced multiple failed IVF cycles or recurrent pregnancy loss may benefit from PGD to identify potential genetic factors contributing to these outcomes. By screening embryos for genetic abnormalities, PGD can help improve the chances of a successful pregnancy and live birth in these cases.

It is important for individuals considering PGD to consult with a genetic counselor or fertility specialist to assess their specific risk factors and determine whether PGD is a suitable option for them. While PGD can be a valuable tool for couples at risk of passing on genetic disorders or experiencing fertility challenges, it is essential to weigh the benefits and limitations of the procedure in the context of individual circumstances.